IL6 and Decreased liver function: In one study comparing immunoregulatory cytokines and the impact of Th17 regulatory T-cells in male and female ALD patients, elevated levels of IL-6 and Treg cells were associated with increased severity of liver dysfunction, development of complications, and decreased 90-day survival.